ZyVersa Therapeutics Inc. (ZVSA)

NASDAQ HEALTHCARE
$0.21 +0.33% RSI 50 Neutral Add Alert

Moving Averages

SMA 200
$0.21
Price near

Company Profile

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company is headquartered in Weston, Florida.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.63M
P/E Ratio
None
EPS
$-4.18
Beta
0.702
Dividend Yield
0.00%
52-Week High
$1.19
52-Week Low
$0.11

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0
SRPT
Sarepta Therapeutics Inc
RSI 51.0

Data last updated: April 11, 2026 at 12:37 PM EDT

Track ZVSA for free

Get e-mail RSI alerts when ZyVersa Therapeutics Inc. enters oversold or overbought territory. Free forever.

Add Alert